Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- REGALEIndependent statistical analysis of T-Reg Cell Kinetics, Stem Cell Transplant, REGALE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578539).
- REGARD-PGxIndependent statistical analysis of The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REGENT-1Independent statistical analysis of Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REGKINEIndependent statistical analysis of T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578461).
- Regulatory Request NIS in Korea: Complete Statistical AnalysisIndependent statistical analysis of Regulatory Request NIS in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642717).
- Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288886).
- ReITIrateIndependent statistical analysis of Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies: primary endpoint results, effect estimate with confidence interval,…
- Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers – a Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Relative Bioavailability of Evobrutinib Tablet Batches: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Evobrutinib Tablet Batches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07214922).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).
- Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02572609).
- Relative Bioavailability Study of Emodepside IR-tablets and Solution: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Emodepside IR-tablets and Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03383523).
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: Complete Statistical AnalysisIndependent statistical analysis of Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873987).
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: Complete Statistical AnalysisIndependent statistical analysis of Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: Complete Statistical AnalysisIndependent statistical analysis of Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RELIEFIndependent statistical analysis of LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RELIEFIndependent statistical analysis of REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Relieving Acute Pain (RAP) Study: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Relieving Acute Pain (RAP) Study: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426137).
- REMDACTAIndependent statistical analysis of the REMDACTA phase 3 trial of remdesivir plus tocilizumab versus remdesivir plus placebo in hospitalized participants with severe COVID-19 pneumonia, including time-to-event, logistic regression, and categorical endpoint results.
- Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00818272).
- remifentanilIndependent statistical analysis of Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693185).
- Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: Complete Statistical AnalysisIndependent statistical analysis of Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04265807).
- REMOTE-COVIDIndependent statistical analysis of Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337489).
- RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: Complete Statistical AnalysisIndependent statistical analysis of Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Renin and Renal Biomarker Response to Angiotensin II: Complete Statistical AnalysisIndependent statistical analysis of Renin and Renal Biomarker Response to Angiotensin II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04558359).
- Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: Complete Statistical AnalysisIndependent statistical analysis of Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): Complete Statistical AnalysisIndependent statistical analysis of Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REPLAYIndependent statistical analysis of Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REPRISE IIIIndependent statistical analysis of Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REQUIP RLS PMSIndependent statistical analysis of REQUIP RLS Post Marketing Surveillance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01327339).
- RESCUEIndependent statistical analysis of Renal Safety Evaluation After Dotarem®-Enhanced MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00650845).
- Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: Complete Statistical AnalysisIndependent statistical analysis of Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity – COVID-19 Testing in School With Children and Staff: Complete Statistical AnalysisIndependent statistical analysis of ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff: primary endpoint results, effect estimate with…
- Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: Complete Statistical AnalysisIndependent statistical analysis of Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RESISTIndependent statistical analysis of Aspirin Resistance and Percutaneous Coronary Intervention (PCI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01103440).
- RESISTIndependent statistical analysis of Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03481777).
- RESOLVEIndependent statistical analysis of Tailored Non-Pharmacotherapy Services for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04523714).
- Respiratory Muscle Training (RMT) in ALS: Complete Statistical AnalysisIndependent statistical analysis of Respiratory Muscle Training (RMT) in ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04224961).